Kingdon Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-54,476
| Closed | -$5.41M | – | 149 |
|
|
2016
Q2 | $5.41M | Sell |
54,476
-747,034
| -93% | -$60.4M | 0.3% | 76 |
|
|
2016
Q1 | $42.8M | Sell |
801,510
-104,777
| -12% | -$7.73M | 2.36% | 9 |
|
|
2015
Q4 | $102M | Buy |
906,287
+417,375
| +85% | +$46M | 4.98% | 3 |
|
|
2015
Q3 | $57.5M | Buy |
488,912
+411,904
| +535% | +$53.8M | 2.77% | 7 |
|
|
2015
Q2 | $5.96M | Sell |
77,008
-450,827
| -85% | -$29.6M | 0.23% | 93 |
|
|
2015
Q1 | $30.5M | Sell |
527,835
-491,440
| -48% | -$20.9M | 1.3% | 13 |
|
|
2014
Q4 | $32.9M | Buy |
1,019,275
+91,521
| +10% | +$2.75M | 1.43% | 20 |
|
|
2014
Q3 | $22.7M | Sell |
927,754
-428,093
| -32% | -$8.7M | 1.02% | 25 |
|
|
2014
Q2 | $24M | Buy |
1,355,847
+136,328
| +11% | +$2.19M | 0.92% | 20 |
|
|
2014
Q1 | $24.4M | Sell |
1,219,519
-431,918
| -26% | -$8.37M | 1.24% | 19 |
|
|
2013
Q4 | $27.7M | Sell |
1,651,437
-50,863
| -3% | -$704K | 1.27% | 15 |
|
|
2013
Q3 | $18.1M | Sell |
1,702,300
-255,000
| -13% | -$2.23M | 0.89% | 26 |
|
|
2013
Q2 | $10.9M | Buy |
+1,957,300
| New | +$11.9M | 0.65% | 35 |
|
Kingdon Capital Management's ANAC Position: Q3 2016 in Review
Kingdon Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q3 2016, closing a stake of 54,476 shares — an estimated $5.41M sold.
Kingdon Capital Management first reported a position in ANAC in Q2 2013 and held it in 13 quarters. The position peaked at $102M in Q4 2015. 0 funds tracked by Wall St. Rank hold ANAC as of Q3 2016.
- Kingdon Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q3 2016 after selling out during the quarter.
- Kingdon Capital Management sold 54,476 ANACOR PHARMACEUTICALS INC COM shares in Q3 2016, an estimated $5.41M.
- Kingdon Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 13 quarters.
- Kingdon Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $102M in Q4 2015.
- 0 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q3 2016.
Based on Kingdon Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.